Rooti Rx ECG Event Recorder vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Rooti Labs Ltd.
VS
by Tempus

AI Verdict

Rooti Rx is a wearable device and platform for continuous, multi-day ECG monitoring and comprehensive diagnostic reporting of various cardiac events. In contrast, Tempus ECG-Low EF is an AI software designed to analyze existing 12-lead ECG recordings specifically for signs associated with low left ventricular ejection fraction. Rooti Rx focuses on generating and interpreting new, continuous data, while Tempus ECG-Low EF provides a targeted risk assessment from standard, single-point ECGs.

Choose Rooti Rx ECG Event Recorder if…

Choose Rooti Rx if you require continuous, extended ECG monitoring (up to 7 days) to capture intermittent cardiac events or assess arrhythmia burden in an ambulatory setting. Its compact wearable design and AI-driven platform are ideal for remote patient monitoring, enabling rapid diagnosis of transient symptoms.

View Rooti Rx ECG Event Recorder →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if you need an AI-powered solution to rapidly screen for signs of low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older using standard 12-lead ECG recordings. This tool is best suited for integration into clinical workflows to identify patients at risk of heart failure who may benefit from further diagnostic evaluation.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rooti Rx ECG Event Recorder Tempus ECG-Low EF
Pricing Contact for pricing Unknown
Deployment Cloud-based (RootiCare platform on AWS) and device-based Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rooti Rx ECG Event Recorder

Rooti Rx offers a more comprehensive and interactive user experience for both patients and clinicians. Its wearable device, mobile event marking, and online review and editing platform provide a flexible workflow. Tempus ECG-Low EF, while integrated into workflows, primarily provides a binary output, offering less direct user interaction.

Clinical Value

Tempus ECG-Low EF

Tempus ECG-Low EF provides a highly specific, FDA-cleared AI solution for detecting low Left Ventricular Ejection Fraction (LVEF) from routine ECGs, a critical indicator for heart failure risk. This targeted detection, backed by a large training dataset and clinical validation, offers significant value for early intervention. Rooti Rx provides broader continuous cardiac monitoring and reporting.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information. Without transparent or comparable pricing details, it is impossible to assess their relative value proposition.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared and HIPAA compliant. Rooti Rx leverages a cloud-based (AWS) deployment, while Tempus ECG-Low EF is designed for integration into existing healthcare facility workflows, both suitable for enterprise environments.

Innovation

Tempus ECG-Low EF

Tempus ECG-Low EF's innovation lies in its ability to apply advanced AI to standard 12-lead ECGs to non-invasively detect a specific, critical physiological condition like low LVEF, which traditionally requires more complex imaging. This extracts novel, actionable insights from existing data. Rooti Rx innovates with wearable ECG technology and AI-assisted reporting for continuous monitoring.

Support & Docs

Tie

Neither the provided structured facts nor web searches yielded specific details about public documentation portals, detailed support plans, or service level agreements for either product. Both companies indicate that customer support is available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rooti Rx ECG Event Recorder Tempus ECG-Low EF
Product Type Compact, wearable ECG event recorder AI software for 12-lead ECG analysis
Primary Function Continuous cardiac monitoring and rapid, accurate diagnostic reports Detects signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%)
ECG Input Type Single or three-channel wearable ECG device Resting, non-ambulatory 12-lead ECG recordings
Recording/Analysis Duration Up to 7-day ECG and actigraphy recording Analyzes existing ECG recordings (duration not specified)
Output AI-driven interpretation, quality assurance checks, online ECG review/editing, fast report generation within 24 hours Binary output (Low LVEF Detected / Not Detected)
Target Patient/Condition General cardiac monitoring Patients 40 years or older at risk of heart failure, detecting low LVEF

Videos

Demos, reviews, and walkthroughs featuring Rooti Rx ECG Event Recorder and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rooti Rx is a wearable ECG event recorder designed for continuous cardiac monitoring and rapid, accurate diagnostic reports for various cardiac events. Tempus ECG-Low EF is an AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
Rooti Rx uses a compact, wearable ECG device for up to 7 days of continuous ECG and actigraphy recording, with data uploaded via Wi-Fi to its cloud-based RootiCare platform. Tempus ECG-Low EF analyzes existing resting, non-ambulatory 12-lead ECG recordings collected at a healthcare facility.
Rooti Rx provides 24-bit high-resolution ECG images, AI-driven interpretation, online ECG review and editing, and fast report generation within 24 hours. Tempus ECG-Low EF delivers a binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation for low LVEF.
Rooti Rx is intended for general cardiac monitoring and event recording for patients requiring continuous assessment. Tempus ECG-Low EF specifically targets patients 40 years or older at risk of heart failure, to identify signs associated with low LVEF.
Rooti Rx focuses on continuous ECG event recording and general cardiac diagnosis, providing high-resolution ECGs and AI interpretation. It is not specifically designed or cleared to detect low LVEF as a primary function. Tempus ECG-Low EF is an FDA-cleared AI software specifically for detecting signs associated with low LVEF (u226440%) from 12-lead ECGs.
Rooti Rx offers up to 7-day continuous ECG and actigraphy recording. Tempus ECG-Low EF analyzes single, resting, non-ambulatory 12-lead ECG recordings.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.